|
ACE/Angiotension receptors
Citations 41-50 of 225 total displayed.
|
Past content
(since Jun 1999):
|
- Vascular Medicine
Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E–Null Mice
- Masaru Iwai, Rui Chen, Zhen Li, Tetsuya Shiuchi, Jun Suzuki, Ayumi Ide, Masahiro Tsuda, Midori Okumura, Li-Juan Min, Masaki Mogi, and Masatsugu Horiuchi
Circulation 2005;112:1636-1643; published online before print as doi:10.1161/CIRCULATIONAHA.104.525550
[Abstract]
[Full text]
- Articles
Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart Failure. Roles of Angiotensin II Type 1 Receptors and NAD(P)H Oxidase
- Lie Gao, Wei Wang, Yu-Long Li, Harold D. Schultz, Dongmei Liu, Kurtis G. Cornish, and Irving H. Zucker
Circulation published September 12, 2005, doi:10.1161/CIRCULATIONAHA.105.552174
[Abstract]
- Articles
Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E-Null Mice
- Masaru Iwai, Rui Chen, Zhen Li, Tetsuya Shiuchi, Jun Suzuki, Ayumi Ide, Masahiro Tsuda, Midori Okumura, Li-Juan Min, Masaki Mogi, and Masatsugu Horiuchi
Circulation published September 6, 2005, doi:10.1161/CIRCULATIONAHA.104.525550
[Abstract]
- Hypertension
Increased Expression of Mineralocorticoid Effector Mechanisms in Kidney Biopsies of Patients With Heavy Proteinuria
- Marcus Quinkler, Daniel Zehnder, Kevin S. Eardley, Julia Lepenies, Alexander J. Howie, Susan V. Hughes, Paul Cockwell, Martin Hewison, and Paul M. Stewart
Circulation 2005;112:1435-1443, doi:10.1161/CIRCULATIONAHA.105.539122
[Abstract]
[Full text]
- Heart Failure
Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure
- Salim Yusuf, Jan B. Ostergren, Hertzel C. Gerstein, Marc A. Pfeffer, Karl Swedberg, Christopher B. Granger, Bertil Olofsson, Jeffrey Probstfield, John V. McMurray on behalf of the Candesartan in Heart Failure—Assessment of Reduction in Mortality and Morbidity Program (CHARM) Investigators
Circulation 2005;112:48-53; published online before print as doi:10.1161/CIRCULATIONAHA.104.528166
[Abstract]
[Full text]
- Epidemiology
Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) Study
- Donna K. Arnett, Barry R. Davis, Charles E. Ford, Eric Boerwinkle, Cathie Leiendecker-Foster, Michael B. Miller, Henry Black, and John H. Eckfeldt
Circulation 2005;111:3374-3383; published online before print as doi:10.1161/CIRCULATIONAHA.104.504639
[Abstract]
[Full text]
- Articles
Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment. The Genetics of Hypertension-Associated Treatment (GenHAT) Study
- Donna K. Arnett, Barry R. Davis, Charles E. Ford, Eric Boerwinkle, Cathie Leiendecker-Foster, Michael B. Miller, Henry Black, and John H. Eckfeldt
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.504639
[Abstract]
- Correspondence
Letter Regarding Article by Devereux et al, "Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial"
- Michael F. O’Rourke and Michel E. Safar
Circulation 2005;111:e377, doi:10.1161/CIRCULATIONAHA.104.525519
[Full text]
- Hypertension
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
- Carlos M. Ferrario, Jewell Jessup, Mark C. Chappell, David B. Averill, K. Bridget Brosnihan, E. Ann Tallant, Debra I. Diz, and Patricia E. Gallagher
Circulation 2005;111:2605-2610; published online before print as doi:10.1161/CIRCULATIONAHA.104.510461
[Abstract]
[Full text]
- AHA Scientific Statements
Practical Implementation of the Guidelines for Unstable Angina/Non–ST-Segment Elevation Myocardial Infarction in the Emergency Department: A Scientific Statement From the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers
- W. Brian Gibler, Christopher P. Cannon, Andra L. Blomkalns, Douglas M. Char, Barbara J. Drew, Judd E. Hollander, Allan S. Jaffe, Robert L. Jesse, L. Kristin Newby, E. Magnus Ohman, Eric D. Peterson, and Charles V. Pollack
Circulation 2005;111:2699-2710, doi:10.1161/01.CIR.0000165556.44271.BE
[Abstract]
[Full text]
|
|
